Abstract
The alarming increase of antimicrobial resistance has led to a growing number of studies aiming to develop novel antimicrobial therapeutics. Natural antimicrobial peptides possess a potent and broad-spectrum antimicrobial activity combined with diverse and unique structural motifs, which confer their different mechanisms of action. These peptides are ubiquitous in organisms and are integral to the innate immune system. Recently, identification of antimicrobial peptides from marine crustaceans has become the centre of attention of many researchers. This increasing interest stems from the remarkable diversity in the structural and genetic composition of these peptides compared to terrestrial counterparts. Thus, peptides from marine crustaceans can serve as future templates for novel antimicrobial agents. Here, we provide an overview of various antimicrobial peptides from the marine crustaceans, their antimicrobial activity and structure- activity relationships. We also discuss the potential and challenges of their development as new antimicrobial agents.
Keywords: Antimicrobial activity, structure-activity relationship, antimicrobial peptides, mechanism of action, marine peptides, crustaceans.
Current Medicinal Chemistry
Title:Antimicrobial Peptides of Marine Crustaceans: The Potential and Challenges of Developing Therapeutic Agents
Volume: 25 Issue: 19
Author(s): Negar T. Zanjani, Monica Miranda-Saksena, Anthony L. Cunningham*Fariba Dehghani*
Affiliation:
- Centre for Virus Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW,Australia
- The University of Sydney, School of Chemical and Biomolecular Engineering, Sydney, NSW,Australia
Keywords: Antimicrobial activity, structure-activity relationship, antimicrobial peptides, mechanism of action, marine peptides, crustaceans.
Abstract: The alarming increase of antimicrobial resistance has led to a growing number of studies aiming to develop novel antimicrobial therapeutics. Natural antimicrobial peptides possess a potent and broad-spectrum antimicrobial activity combined with diverse and unique structural motifs, which confer their different mechanisms of action. These peptides are ubiquitous in organisms and are integral to the innate immune system. Recently, identification of antimicrobial peptides from marine crustaceans has become the centre of attention of many researchers. This increasing interest stems from the remarkable diversity in the structural and genetic composition of these peptides compared to terrestrial counterparts. Thus, peptides from marine crustaceans can serve as future templates for novel antimicrobial agents. Here, we provide an overview of various antimicrobial peptides from the marine crustaceans, their antimicrobial activity and structure- activity relationships. We also discuss the potential and challenges of their development as new antimicrobial agents.
Export Options
About this article
Cite this article as:
Zanjani T. Negar , Miranda-Saksena Monica, Cunningham L. Anthony*, Dehghani Fariba*, Antimicrobial Peptides of Marine Crustaceans: The Potential and Challenges of Developing Therapeutic Agents, Current Medicinal Chemistry 2018; 25 (19) . https://dx.doi.org/10.2174/0929867324666171106155936
DOI https://dx.doi.org/10.2174/0929867324666171106155936 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pan-Vertebrate Toll-Like Receptors During Evolution
Current Genomics Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
Current Medicinal Chemistry YB-1 Activities in Oncogenesis: Transcription and Translation
Current Cancer Therapy Reviews Enzyme / Abzyme Prodrug Activation Systems: Potential Use in Clinical Oncology
Current Pharmaceutical Design Lifestyle Choices and Endothelial Function: Risk and Relevance
Current Vascular Pharmacology Oxidative Stress and Cancer: The Role of Nrf2
Current Cancer Drug Targets Tyrosol and Hydroxytyrosol Two Main Components of Olive Oil, Protect N2a Cells Against Amyloid-β-Induced Toxicity. Involvement of the NF-κB Signaling
Current Alzheimer Research Cognitive Impairment in Systemic Lupus Erythematosus: Prevalence and Clinical Importance
Current Rheumatology Reviews Plant Antimicrobial Peptides: An Overview of SuperSAGE Transcriptional Profile and a Functional Review
Current Protein & Peptide Science Microbes, Immunity and Multiple Sclerosis: An Update
Current Immunology Reviews (Discontinued) Oxidative Stress, Preeclampsia and Cardiovascular Disease
Current Hypertension Reviews Clinical Pharmacogenetics and Potential Application in Personalized Medicine
Current Drug Metabolism Cholinergic Receptors as Target for Cancer Therapy in a Systems Medicine Perspective
Current Molecular Medicine Immunogenetic Mechanisms Leading to Thyroid Autoimmunity: Recent Advances in Identifying Susceptibility Genes and Regions
Current Genomics Heterocyclic Analogues as Kinase Inhibitors: A Focus Review
Current Topics in Medicinal Chemistry Renal Cell Cancer and Positron Emission Tomography- an Evolving Diagnostic and Therapeutic Relationship
Current Medical Imaging Targeting Proteasomal Pathways by Dietary Curcumin for Cancer Prevention and Treatment
Current Medicinal Chemistry A New Approach for Skin-Derived Precursors to Ameliorate Skin Photodamage Through Activation of Nrf2 Signaling Pathway
Current Signal Transduction Therapy Macrophage Activation and HIV Infection: Can the Trojan Horse Turn into a Fortress?
Current Molecular Medicine Future Therapeutic Strategies in Inflammatory Cardiomyopathy: Insights from the Experimental Autoimmune Myocarditis Model
Cardiovascular & Hematological Disorders-Drug Targets